Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Translating Surgical Transfusion Evidence into Practice: A Multicenter Prospective Observational Study
37 Pages Posted: 14 Jul 2020
More...Abstract
Background: Randomized controlled trials have confirmed the safety of a restrictive red-cell tranfusion threshold (8 g/dL) versus a liberal threshold in cardiac and orthopedic surgeries. We aim to examine whether these findings can be replicated with observational data and generalized to broader specialties and a lower threshold.
Methods: This is a prospective observational study conducted in three region-representative hospitals in China. Inpatients aged ≥18 years undergoing surgeries from six red cell-consumptive specialties (2015–2016) were defined as the base population. Three criteria were used to derive an analytic population: no significant intraoperative bleeding (<500 mL); hemoglobin at 7–10g/dL; and stratified by specialties (CCV and nonCCV group). Propensity-score matching was used to minimize confounding effect when necessary.
Findings: Of 36 607 patients, 3930 (10·7%) received transfusion. The transfusion rate significantly increased with the intraoperative bleeding and decreased with the hemoglobin (p trend <0·0001). After applying the three criteria and propensity-score matching, transfusion was unrelated with death (OR [95% CI]: CCV, 1·51 [0·25–9·23]; nonCCV, 1·41 [0·44–4·46]), composite complication (CCV, 1·36 [0·63–2·95]; nonCCV, 1·61 [0·98–2·66]), but was related with infection in nonCCV (2·15 [1·12–4·12]). Patient outcomes showed no significant differences after transfusions at hemoglobin of 7–8g/dL vs. 8–10g/dL.
Interpretation: We have replicated the findings of transfusion RCTs in six specialties and a lower threshold. Tailoring both the design and analysis is crucial for using observational data to generalize RCT evidence into wide surgical transfusion practice.
Funding Statement: The National Health and Family Planning Commission of China (no. 201402017).
Declaration of Interests: Authors have nothing to disclose.
Ethics Approval Statement: The need for written informed consent was waived by the institutional review board of Peking Union Medical College Hospital (the leading research site of MSCP; date: July 26th, 2013; no. S-574) considering that the project was a quality improvement endeavor and individual information was analyzed anonymously.
Keywords: RBC tranfusion; transfusion threshold; surgical outcomes; randomized controlled trial; observational study
Suggested Citation: Suggested Citation